78441-57-3

Basic information

• Product Name: Carbamic acid, (cyanomethyl)methyl-, phenyl ester
• CAS NO: 78441-57-3
• Molecular Formula: C10H10N2O2
• Molecular Weight: 190.202
• Mol File: 78441-57-3.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: Carbamic acid, (cyanomethyl)methyl-, phenyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Carbamic acid, (cyanomethyl)methyl-, phenyl ester(78441-57-3)
• EPA Substance Registry System: Carbamic acid, (cyanomethyl)methyl-, phenyl ester(78441-57-3)

Safety Data

• Hazardous Substances Data: 78441-57-3(Hazardous Substances Data)

Upstream product

• 25808-30-4 2-(methylamino)acetonitrile hydrochloride 
• 1885-14-9 phenyl chloroformate 

Relevant articles and documents

HISTAMINE H2-ANTAGONISTS

Histamine H 2-antagonists of the formula STR1 wherein p is 1 or 2; R 1 is hydroxy, amino, substituted amino or a 5-to 9-membered fully saturated nitrogen-containing heterocyclic ring attached via its nitrogen atom; m is an integer of from 0 to 2, n is an integer of from 2 to 4; Z is sulfur, oxygen or methylene; and A is an optionally substituted phenyl, imidazolyl, thiazolyl, isothiazolyl, oxazolyl, isoxazolyl, triazolyl, thiadiazolyl, oxadiazolyl, furyl, thienyl or pyridyl ring; and nontoxic pharmaceutically acceptable salts, hydrates, solvates or N-oxides thereof are novel anti-ulcer agents. Intermediates and processes for their preparation are disclosed.

CHEMICAL COMPOUNDS

Histamine H 2-antagonists of the formula STR1 wherein p is 1 or 2; R 1 is hydroxy, amino, substituted amino or a 5-to 9-membered fully saturated nitrogen-containing heterocyclic ring attached via its nitrogen atom; m is an integer of from 0 to 2; n is an integer of from 2 to 4; Z is sulfur, oxygen or methylene; and A is an optionally substituted phenyl, imidazolyl, thiazolyl, isothiazolyl, oxazolyl, isoxazolyl, triazolyl, thiadiazolyl, oxadiazolyl, furyl, thienyl or pyridyl ring; and nontoxic pharmaceutically acceptable salts, hydrates, solvates or N-oxides thereof are novel anti-ulcer agents. Intermediates and processes for their preparation are disclosed.